Quotient Insiders
QTNTDelisted Stock | USD 0.04 0.00 0.00% |
Quotient employs about 450 people. The company is managed by 23 executives with a total tenure of roughly 122 years, averaging almost 5.0 years of service per executive, having 19.57 employees per reported executive. Breaking down Quotient's management performance can provide insight into the firm performance.
Paul Cowan Chairman Chairman of the Board, CEO |
Jeremy Stackawitz President President |
Quotient |
Quotient Management Team Effectiveness
The company has return on total asset (ROA) of (0.4028) % which means that it has lost $0.4028 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.3771) %, meaning that it created substantial loss on money invested by shareholders. Quotient's management efficiency ratios could be used to measure how well Quotient manages its routine affairs as well as how well it operates its assets and liabilities.Quotient Workforce Comparison
Quotient is currently regarded as top stock in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 183,332. Quotient adds roughly 450 in number of employees claiming only tiny portion of equities under Health Care industry.
Quotient Notable Stakeholders
A Quotient stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Quotient often face trade-offs trying to please all of them. Quotient's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Quotient's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Paul Cowan | Chairman of the Board, CEO | Profile | |
Jeremy Stackawitz | President | Profile | |
Edward Farrell | President | Profile | |
Christopher Lindop | CFO, Principal Financial Officer | Profile | |
Frederick Hallsworth | Independent Director | Profile | |
Thomas Bologna | Independent Director | Profile | |
Heino Prondzynski | Lead Independent Director | Profile | |
Brian McDonough | Independent Director | Profile | |
Zubeen Shroff | Director | Profile | |
Sarah OConnor | Director | Profile | |
Franz Walt | Director | Profile | |
John Wilkerson | Director | Profile | |
Mohammad Khoury | Chief Officer | Profile | |
Christine Ginocchio | Chief Officer | Profile | |
Christian Albrich | Chief Officer | Profile | |
Esteban Uriarte | Chief Officer | Profile | |
Roland Boyd | Group Financial Controller and Treasurer | Profile | |
Ali Kiboro | Chief Officer | Profile | |
Vittoria Bonasso | Group Fin | Profile | |
Viviane Montarnal | Head Compliance | Profile | |
Michael Hausmann | Chief Officer | Profile | |
Hyatt AntogniniAmin | Head Communications | Profile | |
Manuel Mendez | CEO Director | Profile |
About Quotient Management Performance
The success or failure of an entity such as Quotient often depends on how effective the management is. Quotient management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Quotient management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Quotient management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland. Quotient operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.
The data published in Quotient's official financial statements usually reflect Quotient's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Quotient. For example, before you start analyzing numbers published by Quotient accountants, it's critical to develop an understanding of what Quotient's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Quotient's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Quotient's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Quotient's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Quotient. Please utilize our Beneish M Score to check the likelihood of Quotient's management manipulating its earnings.
Quotient Workforce Analysis
Traditionally, organizations such as Quotient use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Quotient within its industry.Quotient Manpower Efficiency
Return on Quotient Manpower
Revenue Per Employee | 85.6K | |
Revenue Per Executive | 1.7M | |
Net Loss Per Employee | 278.1K | |
Net Loss Per Executive | 5.4M | |
Working Capital Per Employee | 89.7K | |
Working Capital Per Executive | 1.8M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Quotient Stock
If you are still planning to invest in Quotient check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Quotient's history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Global Correlations Find global opportunities by holding instruments from different markets |